Technical Analysis for NVCR - NovoCure Limited

Grade Last Price % Change Price Change
grade D 77.84 -1.34% -1.06
NVCR closed down 1.34 percent on Thursday, December 12, 2019, on 1.7 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
See historical NVCR trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
New Downtrend Bearish 0.00%
Hammer Candlestick Bullish 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -1.34%
Multiple of Ten Bearish Other -1.34%
Older signals for NVCR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Medicine Cancer Clinical Medicine Oncology Tumor Non Small Cell Lung Cancer Ovarian Cancer Glioblastoma Pancreatic Cancer Aging Associated Diseases Brain Tumor European Union Solid Tumor Cancers Mesothelioma

Is NVCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 98.7
52 Week Low 28.83
Average Volume 703,760
200-Day Moving Average 67.51
50-Day Moving Average 79.99
20-Day Moving Average 86.98
10-Day Moving Average 84.54
Average True Range 3.26
ADX 26.06
+DI 13.61
-DI 36.18
Chandelier Exit (Long, 3 ATRs ) 86.36
Chandelier Exit (Short, 3 ATRs ) 85.89
Upper Bollinger Band 96.82
Lower Bollinger Band 77.13
Percent B (%b) 0.04
BandWidth 22.64
MACD Line -0.13
MACD Signal Line 1.70
MACD Histogram -1.8312
Fundamentals Value
Market Cap 6.92 Billion
Num Shares 88.9 Million
EPS -1.09
Price-to-Earnings (P/E) Ratio -71.41
Price-to-Sales 13.08
Price-to-Book 13.88
PEG Ratio -0.41
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 81.64
Resistance 3 (R3) 81.48 80.06 81.00
Resistance 2 (R2) 80.06 79.09 80.14 80.79
Resistance 1 (R1) 78.95 78.50 78.24 79.11 80.58
Pivot Point 77.53 77.53 77.18 77.61 77.53
Support 1 (S1) 76.42 76.56 75.71 76.58 75.10
Support 2 (S2) 75.00 75.97 75.08 74.89
Support 3 (S3) 73.89 75.00 74.68
Support 4 (S4) 74.05